Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Dec. 31, 2013	Dec. 31, 2012
Cash flows from operating activities
Net loss	$ (6,676)	$ (6,043)
Depreciation and amortization	1,560	760
Income tax provision (benefit)	(1,026)	35
Non-cash interest expense	62	1,934
Change in fair value of conversion option liability	0	(289)
Share‑based compensation	1,583	661
Accounts receivable	(1,107)	7
Prepaid expenses and other assets	(594)	(200)
Deferred revenue, including long-term portion	1,789	(20)
Accounts payable	(278)	636
Accrued expenses and other	(1,437)	432
Net cash used in operating activities	(6,124)	(2,087)
Cash flows from investing activities
Decrease in restricted cash	1,000	0
Purchases of property and equipment, including software development costs	(1,351)	(19)
Acquisitions of businesses, net of cash acquired	(34,880)	0
Net cash used in investing activities	(35,231)	(19)
Cash flows from financing activities
Partner’s investment in joint venture	0	208
Principal payments on loan payable	(10,223)	0
Payments on capital leases	(190)	0
Proceeds from debt issuances	64	0
Proceeds from Issuance or Sale of Equity	2,173	0
Deferred finance and offering costs	(1,032)	(386)
Net cash used in financing activities	(9,208)	(178)
Effect of changes in foreign exchange rates on cash and cash equivalents	(35)	0
Net decrease in cash and cash equivalents	(50,598)	(2,284)
Cash and cash equivalents, beginning of period	127,728	4,174
Cash and cash equivalents, end of period	77,130	1,890
Supplemental Cash Flow Information [Abstract]
Cash paid for interest	56	149
Accretion	70	76
Assets acquired under capital lease	0	350
Deferred offering and financing costs	0	624
Redeemable Preferred Stock, Series A-1 [Member]
Supplemental Cash Flow Information [Abstract]
Accretion	0	165
Redeemable Non-Controlling Interest [Member]
Supplemental Cash Flow Information [Abstract]
Accretion	$ 70	$ 76